Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00022883
DRKS00022883
Not Yet Recruiting
N/A

Influence of Botulinum Toxin A injections into the calf muscles on the recurvation of the knee joint in patients with spastic infantile cerebral palsy

niversitätsklinik HeidelbergKlinik für Orthopädie und Unfallchirurgie0 sites20 target enrollmentOctober 27, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsG80.0Q66.0Spastic quadriplegic cerebral palsyTalipes equinovarus

Overview

Phase
N/A
Intervention
Not specified
Conditions
G80.0
Sponsor
niversitätsklinik HeidelbergKlinik für Orthopädie und Unfallchirurgie
Enrollment
20
Status
Not Yet Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 27, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinik HeidelbergKlinik für Orthopädie und Unfallchirurgie

Eligibility Criteria

Inclusion Criteria

  • •The diagnosis: Spastic cerebral palsy (GMFCS Level I\-II) and simultaneously present Genu Rekurvatum (knee joint extension \= 5° in the 3\-D gait analysis) with dynamic pointed foot (dorsal extension in the clinical examination \=0°, tip\-toe gait in the 3\-D gait analysis).
  • •Standardized clinical examination and instrumental 3D gait analysis directly before
  • •Botox treatment and 6 weeks after botulinum toxin A injection.

Exclusion Criteria

  • •Pre\-operative treatment of the lower extremity Refusal to use the data already collected and wish to discontinue studies
  • •by the patient or the parents/legal representatives
  • •Botulinum toxin A injection within the last 6 months
  • •Walking aids (GMFCS III)
  • •Severe mental disability
  • •Non Compliance

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
N/A
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. - Botulinum toxin type A injections in stiff knee gaitStroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.
EUCTR2009-018226-29-NL26
Completed
Phase 3
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gaitstiff knee gaitstiff-legged knee1000796310057166
NL-OMON39359Revalidatiecentrum Het Roessingh26
Active, Not Recruiting
N/A
Effect of Botulinum Toxin A Injections and Specific Intensive Rehabilitation Therapy in Children with Hemiparetic Cerebral Palsy on Upper Limb Functions and Skills - BoBiVa (Botuline toxine Bimanuele Vaardigheden)Study design: a factorial design with four study groups in which btA alone, intensive rehabilitation therapy aimed at improving bimanual skills alone, a combination of these two and continuing the regular therapy program will be compared to each other.Study population: children with CP, spastic hemiparesis, aged 2.5 – 12 years.
EUCTR2006-002175-40-NL60
Completed
Phase 3
Effect of Botulinum Toxin A Injections and Specific Intensive Rehabilitation Therapy in Children with Hemiparetic Cerebral Palsy on Upper Limb Functions and Skillscongenital hemiparesisSpastic hemiparetic cerebral palsy10010335
NL-OMON30186Hoensbroek Revalidatiecentrum (HRC)60
Not Yet Recruiting
N/A
The effect of botulinum toxin-A(BTX-A) injection for equinovarus deformity in children with unilateral cerebral palsy.Diseases of the nervous system
KCT0000530Yonsei University Health System, Severance Hospital30